Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus

NACompletedINTERVENTIONAL

Enrollment

340

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions

Non-alcoholic Fatty Liver Disease (NAFLD)

Interventions

DEVICE

Controlled Attenuation Parameter (CAP), Echosens, Paris, France

DEVICE

FibroScan, Echosens, Paris, France

Trial Locations (1)

University Hospital Frankfurt, Frankfurt am Main

All Listed Sponsors

lead

Johann Wolfgang Goethe University Hospital

OTHER

NCT01997424 - Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus | Biotech Hunter | Biotech Hunter